Comparison of the effects of tamoxifen ovulation induction program and hormone replacement program in preparation of frozen embryo transplantation in patients with thin endometrial endometrium

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043820

Enrollment

Unknown

Registered

2021-03-04

Start date

2021-03-08

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with thin endometrium

Interventions

TAM group:TAM

HRT group:Procarl

Eligibility

Sex/Gender

Female

Age

No minimum to 38 Years

Inclusion criteria

Inclusion criteria: 1. Subjects under 38 years old; 2. Subjects with endometrial thickness less than 7mm in previous natural cycles or ovulation induction cycles (except CC cycles); 3. For the subjects with more than 2 frozen embryos, at least one high-quality embryo was transferred.

Exclusion criteria

Exclusion criteria: 1. Those patients who used other drugs to induce ovulation before embryo transfer; 2. Patients with adenomyosis, endometriosis with stage rafs3 or above and history of endometrial tuberculosis; 3. Patients after breast cancer surgery.

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate;Live birth rate;	—

Secondary

Measure	Time frame
Intimal membrane thickness at transformation day;Endometrial thickness on transplantation day;Estradiol on transplant day;Progesterone;Birth defect rate;Cycle cancellation rate;	—

Countries

China

Contacts

Public ContactJing Shu

Zhejiang Provincial People's Hospital

shujing@hmc.edu.cn+86 13805705568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026